Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takeya Kitta has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Deterioration of pelvic floor muscle function and prolonged urethral dysfunction in a rat model of simulated birth trauma

    by Yui Abe-Takahashi, Takeya Kitta, Mifuka Ouchi, Hiroki Chiba, Madoka Higuchi, Mio Togo, Naohisa Kusakabe, Hidehiro Kakizaki, Nobuo Shinohara, Takashige Abe

    Background: Vaginal delivery is a major stress urinary incontinence (SUI) risk factor; simulated birth trauma in rats causes subacute pelvic floor muscle (PFM) and urethral changes, but mid- to long-term effects remain unclear. We aimed to investigate the mid- to long-term effects of simulated birth trauma on PFM composition and urethral function in a rat model of SUI after simulated birth trauma. Methods: Eighteen female Sprague-Dawley rats were divided into sham, 4 weeks (4W), and 12 weeks (12W) post-vaginal distention (VD) groups. Urethral function was evaluated by measuring the amplitude of urethral response to electrical stimulation (A-URE). Muscle wet weights of the iliococcygeus (Icm) and pubococcygeus (Pcm) muscles were measured, and muscle fibers were classified as types I, IIa, and IIb. Cross-sectional area (CSA) and occupancy of each fiber type were determined. To assess the chronological progression of injury, newly acquired 12W data were compared with the sham and 4W data from our previous study. Results: A-URE was significantly lower in the 4W group than in the sham group. Pcm muscle weight was significantly lower in both 4W and 12W groups compared to the sham. Type I fiber ratios in Pcm and Icm were significantly lower in the 4W and 12W groups than in sham, while CSA of Pcm type I fibers was significantly higher in the 12W than in the 4W group. Conclusions: Our results suggest that VD is associated with mid- to long-term changes in PFM composition and decreased muscle endurance, which may contribute to prolonged urethral dysfunction.

  • Open Access

    A Survey on Real‐World Transurethral Surgery Procedures for Bladder Pain Syndrome and Interstitial Cystitis

    by Niimi Aya, Akiyama Yoshiyuki, Furuta Akira, Matsuo Tomohiro, Kitta Takeya, Otsuka Atsushi, Mitsui Takahiko, Masumori Naoya, Matsukawa Yoshihisa, Torimoto Kazumasa, et al.

    Objectives: To investigate real‐world practices in transurethral surgeries for bladder pain syndrome (BPS) and interstitial cystitis (IC) in Japan, with a focus on procedural characteristics of hydrodistension (HD) and transurethral elimination of Hunner lesions (TUEH). Methods: An internet‐based questionnaire was sent to all members of the Society of Interstitial Cystitis of Japan in November 2024. The survey inquired about institutional characteristics, the number of procedures performed in the previous 12 months, and detailed surgical techniques. BPS was defined by the absence of Hunner lesions, and IC by their presence. Responses were analyzed to describe procedural patterns and compare practices between HD and TUEH. Results: Of 205 eligible members, 86 responded (response rate: 42%). Among them, 52 had performed HD for BPS and 67 had performed TUEH for IC within the study period. Most surgeons distended the bladder to a preset pressure of ≤ 80 cm H 2 O for 3–10 min and repeated the procedure at least twice during HD. At TUEH, coagulation was preferred over resection to eliminate Hunner lesions. HD was frequently co‐performed, though the sequence of elimination and HD varied. Compared to HD, TUEH more often relied on abdominal palpation rather than fixed pressure, used shorter distension time, and involved longer catheter placement. Conclusions: This nationwide survey highlights contemporary surgical practices for BPS and IC in Japan. These findings may help clinicians evaluate and refine their own approaches to transurethral interventions for these complex conditions.

  • Open Access

    Sacubitril/valsartan improves nocturia in hypertensive patients: a pilot study

    by Takeya Kitta, Hidehiro Kakizaki, Hajime Kihara

    Nocturia is associated with falls, reduced quality of life (QOL), and sleep disturbances, yet remains underdiagnosed and undertreated. Its multifactorial etiology includes reduced bladder capacity, nocturnal polyuria (NP), and comorbid conditions like hypertension. While antihypertensive therapies have been linked to nocturia, the impact of newer agents remains unclear. This study investigated whether sacubitril/valsartan (Sac/Val), a novel angiotensin receptor-neprilysin inhibitor used for refractory hypertension, could improve nocturia. Sac/Val’s unique natriuretic and diuretic effects may influence NP through modulation of neurohormonal pathways. Eighteen hypertensive patients with nocturia (mean age 66.7 years) were evaluated over 12 weeks. The primary outcome was change in nighttime voiding frequency, assessed via voiding diaries. Secondary outcomes included Pittsburgh Sleep Quality Index-Japanese Version (PSQI-J), Nocturia Quality of Life Questionnaire (N-QOL), Overactive Bladder Symptom Score (OABSS), International Prostate Symptom Score (IPSS), and overall QOL. Results showed a significant reduction in nighttime voids (from 3.31 to 2.10) and nocturnal polyuria index (NPi) (from 48.1% to 39.7%). Sleep quality (PSQI-J) and nocturia-related QOL (N-QOL) also improved. No significant changes were observed in IPSS or general QOL scores, while OABSS nocturia scores decreased. This is the first study to demonstrate Sac/Val’s potential to improve nocturia, likely via its effects on NP and blood pressure (BP). The present study suggests that cardiovascular disease (CVD) may be an often-overlooked factor in the cause of nocturia. Therefore, a multidisciplinary approach is essential for the management of NP, and there is a need to promote collaboration between specialties with an emphasis on developing more patient-specific treatments.

  • Open Access

    Associations between urinary phthalate metabolites and reproductive, adrenal, and gonadotropic hormones in peripubertal children: the Hokkaido study

    by Ayaka Yasuda, Yu Ait Bamai, Takeshi Yamaguchi, Rahel Mesfin Ketema, Yi Zeng, Megasari Marsela, Yoshinori Ikenaka, Akie Nakamura, Takeya Kitta, Masafumi Kon, et al.


  • Validation of the area under the Watts factor curve during the voiding cycle as a novel parameter for diagnosing detrusor underactivity in females

    by Takeya Kitta, Naoki Wada, Satoshi Shinohara, Nagisa Hayashi, Hayato Yamamura, Takayuki Yamamoto, Haruka Takagi, Tsubasa Hatakeyama, Masaya Nagabuchi, Shun Morishita, et al.

    Objective: Detrusor underactivity (DU) is a common cause of lower urinary tract symptoms (LUTS). To date, no consensus has been reached on the urodynamic criteria for defining DU. We previously proposed the area under the curve of the Watts factor (WF‐AUC) as a new parameter for diagnosing DU. By comparing previously reported five criteria for DU and WF‐AUC, we analyzed whether the WF‐AUC could assess detrusor contraction in women with LUTS.Methods: Using urodynamic data of consecutive 77 women with LUTS, first, we classified DU based on previously reported five criteria. Second, we assessed the potential correlation between multiple parameters and WF‐AUC. Third, receiver operating characteristic curve analysis was performed to determine the cutoff value of WF‐AUC for diagnosing DU based on previously reported five criteria. Fourth, a linear regression analysis was conducted and compared using multiple criteria and female bladder outlet obstruction index (BOOIf).Results: WF‐AUC was positively correlated with the maximum values of WF, bladder contractility index (BCI), and projected isovolumetric pressure 1 (PIP1) with correlation coefficients of 0.63, 0.57, and 0.34, respectively. AUC for diagnosing DU based on previously reported five criteria ranging from 0.773 to 0.896 with different cutoff values of AUC‐WF. The Spearman's correlation test revealed that BOOIf was significantly correlated with BCI, but not Wmax, PIP1 and WF‐AUC.Conclusions: This study demonstrated the non‐inferiority of the WF‐AUC compared to previously reported criteria for defining DU. Depending on the cutoff value, the WF‐AUC could appropriately evaluate women with DU, regardless of the presence of BOO.


  • Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial

    by Mifuka Ouchi, Takeya Kitta, Hiroki Chiba, Madoka Higuchi, Yui Abe‐Takahashi, Mio Togo, Naohisa Kusakabe, Sachiyo Murai, Hiroshi Kikuchi, Ryuji Matsumoto, et al.

    Objective: To assess the effectiveness of pre‐ and postoperative supervised pelvic floor muscle training (PFMT) on the recovery of continence and pelvic floor muscle (PFM) function after robot‐assisted laparoscopic radical prostatectomy (RARP). Patients and Methods: We carried out a single‐blind randomised controlled trial involving 54 male patients scheduled to undergo RARP. The intervention group started supervised PFMT 2 months before RARP and continued for 12 months after surgery with a physiotherapist. The control group was given verbal instructions, a brochure about PFMT, and lifestyle advice. The primary outcome was 24‐h pad weight (g) at 3 months after RARP. The secondary outcomes were continence status (assessed by pad use), PFM function, and the Expanded Prostate Cancer Index Composite (EPIC) score. Results: Patients who participated in supervised PFMT showed significantly improved postoperative urinary incontinence (UI) compared with the control group (5.0 [0.0–908.0] g vs 21.0 [0.0–750.0] g; effect size: 0.34, P = 0.022) at 3 months after RARP based on 24‐h pad weight. A significant improvement was seen in the intervention compared with the control group (65.2% continence [no pad use] vs 31.6% continence, respectively) at 12 months after surgery (effect size: 0.34, P = 0.030). Peak pressure during a maximum voluntary contraction was higher in the intervention group immediately after catheter removal and at 6 months, and a longer duration of sustained contraction was found in the intervention group compared with the control group. We were unable to demonstrate a difference between groups in EPIC scores. Conclusion: Supervised PFMT can improve postoperative UI and PFM function after RARP. Further studies are needed to confirm whether intra‐anal pressure reflects PFM function and affects continence status in UI in men who have undergone RARP.


  • Open Access

    Morphological examination of pelvic floor muscles in a rat model of vaginal delivery

    by Yui Abe-Takahashi, Takeya Kitta, Mifuka Ouchi, Hiroki Chiba, Madoka Higuchi, Mio Togo, Naohisa Kusakabe, Hidehiro Kakizaki, Nobuo Shinohara

    Objective: This study investigated morphological changes in the composition of the pelvic floor muscles, degree of atrophy, and urethral function in a rat of simulated birth trauma induced by vaginal distension (VD) model.Methods: Female Sprague–Dawley rats were classified into four groups: a sham group, and 1, 2, and 4 weeks post-VD (1 W, 2 W, and 4 W, respectively) groups. We measured the amplitude of urethral response to electrical stimulation (A-URE) to evaluate urethral function. After measuring the muscle wet weight of the pubococcygeus (Pcm) and iliococcygeus (Icm) muscles, histochemical staining was used to classify muscle fibers into Types I, IIa, and IIb, and the occupancy and cross-sectional area of each muscle fiber were determined.Results: There were 24 Sprague–Dawley rats used. A-URE was significantly lower in the 1 W group versus the other groups. Muscle wet weight was significantly lower in the VD groups versus the sham group for Pcm. The cross-sectional area of Type I Pcm and Icm was significantly lower in the VD groups versus the sham group. Type I muscle fiber composition in Pcm was significantly lower in the VD groups versus the sham groupand lowest in the 2 W group. Type I muscle fiber composition in Icm was significantly lower in the 2 and 4 W groups versus the sham group.Conclusion: Muscle atrophy and changes in muscle composition in the pelvic floor muscles were observed even after improvements in urethral function. These results may provide insight into the pathogenesis of stress urinary incontinence after VD.


  • Effects of a new selective β3‐adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease

    by Mio Togo, Takeya Kitta, Hiroki Chiba, Madoka Higuchi, Naohisa Kusakabe, Mifuka Ouchi, Yui Abe‐Takahashi, Hidehiro Kakizaki, Nobuo Shinohara

    Objectives: Parkinson's disease caused by the loss of dopaminergic neurons induces not only motor dysfunction but also lower urinary tract dysfunction. Patients with Parkinson's disease have recently been reported to experience both urge urinary incontinence (overactive bladder) and stress urinary incontinence, the latter of which occurs when the pressure of the bladder exceeds that of the urethra. Vibegron is a highly selective novel β3‐adrenoceptor agonist approved for the treatment of overactive bladder. However, how β3‐adrenoceptor agonists affect urethral function remains unclear. In a clinical report, the urethral function of patients with Parkinson's disease was shown to be degraded. The present study aimed to investigate the effects of vibegron on lower urinary tract activity in a rat model of Parkinson's disease.Methods: In a rat model of Parkinson's disease induced by unilateral 6‐hydroxydopamine injection into the substantia nigra pars compacta, we examined the effects of vibegron on bladder and urethral activity.Results: Cystometric analysis revealed that, compared with vehicle injection, intravenous injection of 3 mg/kg vibegron significantly increased the inter‐contraction interval (p < .05) and reduced voiding pressure (p < .01). However, no significant effects on urethral function were observed.Conclusions: The results of the present study provide corroborating evidence that bladder dysfunction is suppressed by the administration of vibegron in Parkinson's disease model rats, confirming that vibegron is effective for treating overactive bladder without further worsening urethral function. These findings may contribute to a better understanding of the mechanisms of β3‐adrenoceptor agonists.